Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cavitation Technologies (CVAT) EBIT (2016 - 2025)

Cavitation Technologies' EBIT history spans 16 years, with the latest figure at -$474000.0 for Q4 2025.

  • For Q4 2025, EBIT fell 58.53% year-over-year to -$474000.0; the TTM value through Dec 2025 reached -$1.2 million, down 769.49%, while the annual FY2025 figure was -$987000.0, 325.34% down from the prior year.
  • EBIT for Q4 2025 was -$474000.0 at Cavitation Technologies, down from -$249000.0 in the prior quarter.
  • Across five years, EBIT topped out at $369000.0 in Q2 2024 and bottomed at -$480000.0 in Q2 2021.
  • The 5-year median for EBIT is -$231000.0 (2025), against an average of -$153800.0.
  • The largest YoY upside for EBIT was 249.33% in 2024 against a maximum downside of 2035.71% in 2024.
  • A 5-year view of EBIT shows it stood at -$438000.0 in 2021, then soared by 34.7% to -$286000.0 in 2022, then surged by 95.1% to -$14000.0 in 2023, then plummeted by 2035.71% to -$299000.0 in 2024, then crashed by 58.53% to -$474000.0 in 2025.
  • Per Business Quant, the three most recent readings for CVAT's EBIT are -$474000.0 (Q4 2025), -$249000.0 (Q3 2025), and -$234000.0 (Q2 2025).